EcoR1 Capital
Biotech-focused venture fund. Invests in drug discovery and therapeutic innovation.
San Francisco, United States · 58+ investments · 74 portfolio companies
- Headquarters
- San Francisco, United States
- Founded
- 2012
- Website
- ecor1cap.com
- AUM
- $2.8B
- Portfolio Companies
- 74
- Total Investments
- 58
- Last Investment
- Jan 2026
- Geographic Focus
- G, a, b, l, o, United States
Indexed holds 74 portfolio companies and 58 funding rounds for this investor. The full record is or through the API.
Investment Thesis
EcoR1 Capital is a Venture Capital firm based in San Francisco, United States. It has made 58 investments, including Neogene Therapeutics, Morphic and Kindred Biosciences. Focus areas include Biotech and Drug Discovery.
Portfolio74
Showing 48 of 74 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 171 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×16 · Hedge Fund ×4 · Corporate VC ×2 · 103 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/ecor1-capital"><img src="https://indexed.vc/api/badge/investor/ecor1-capital" alt="EcoR1 Capital on Indexed.vc" width="260" height="76" /></a>